CALYSENS is currently owned by OBRATORI, L'Occitane Group Ventures, through Obratori, since 2021.

When did OBRATORI, L'Occitane Group Ventures acquire CALYSENS?

OBRATORI, L'Occitane Group Ventures acquired CALYSENS in 2021 (active for 5 years).

Home/Companies/Biotech/CALYSENS

CALYSENS

Biotech·

France·Active·5yr hold

CALYSENS is a healthcare company, headquartered in France.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

OBRATORI, L'Occitane Group Ventures

Key facts

HQFrance

SectorHealthcare

Marseille-based medical-lab and cosmetics-research biotech developing skin-biology testing protocols; OBRATORI co-led first funding round…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Obratori

6 comparable biotech deals from other GPs

Start free

Already a member? Sign in

Data refreshed weekly · Sourced from public filings